Does TACROLIMUS Cause Patent ductus arteriosus? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Patent ductus arteriosus have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.0% of all adverse event reports for TACROLIMUS.
28
Reports of Patent ductus arteriosus with TACROLIMUS
0.0%
of all TACROLIMUS reports
1
Deaths
2
Hospitalizations
How Dangerous Is Patent ductus arteriosus From TACROLIMUS?
Of the 28 reports, 1 (3.6%) resulted in death, 2 (7.1%) required hospitalization, and 1 (3.6%) were considered life-threatening.
Is Patent ductus arteriosus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Patent ductus arteriosus?
ONDANSETRON (185)
LAMOTRIGINE (168)
PAROXETINE (168)
ACETAMINOPHEN (154)
VENLAFAXINE (135)
SERTRALINE (130)
LEVETIRACETAM (122)
FLUOXETINE (107)
METOPROLOL (104)
RAMIPRIL (98)
Which TACROLIMUS Alternatives Have Lower Patent ductus arteriosus Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB